United Therapeutics Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$781,500	$790,200	$799,500	$798,600
Gross Profit	648,100	686,800	698,600	711,000
EBITDA	348,400	469,900	462,900	436,800
EBIT	325,800	447,100	441,000	415,700
Net Income	274,900	364,300	338,700	309,500
Net Change In Cash	781,500	790,200	799,500	798,600
Free Cash Flow	362,500	173,300	351,600	129,500
Cash	1,074,200	1,557,100	1,136,600	1,593,100
Basic Shares	47,200	47,900	47,300	48,300

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,182,700	$2,877,400	$2,327,500	$1,936,300
Gross Profit	2,798,300	2,567,700	2,070,000	1,789,600
EBITDA	1,819,000	1,654,400	1,386,800	1,040,300
EBIT	1,733,400	1,581,900	1,333,600	989,000
Net Income	1,334,700	1,195,100	984,800	727,300
Net Change In Cash	3,182,700	2,877,400	2,327,500	1,936,300
Cost of Revenue				66,400
Free Cash Flow	1,040,700	1,080,600	747,600	663,700
Cash	1,557,100	1,697,200	1,207,700	961,200
Basic Shares	47,900	48,500	49,700	48,500